Characteristics of VRIII episodes and patients
| Baseline (November–December 2016) | Peri-intervention (January–March 2017) | Post-intervention (Sepember–November 2017) | Late follow-up (September 2018) | |
| No. of VRIII episodes | 135 | 53 | 127 | 36 |
| No. of corresponding patients | 114 | 51 | 117 | 36 |
| Number of females (%) | 54 (40) | 23 (43.4) | 59 (46.5) | 15 (41.7) |
| Mean age (years) ±SD (range) | 62.1 ±14.4 (19–95) | 61.7 ±15.5 (22–95) | 58.3 ±17.2 (17–89) | 63.1 ±16.3 (26–88) |
| Mean duration (hours) ±SD (range) | 25.2 ±25.3 (4–129) | 30.6 ±43.8 (4–279) | 25.8 ±24.6 (4–114) | 39.6 ±25.8 (5–100) |
VRIII, variable rate intravenous insulin infusions.